Comparative Risk of Angioedema With Sacubitril–Valsartan vs RAAS Inhibitors
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Comparative Risk of Angioedema With Sacubitril-Valsartan vs Renin-Angiotensin-Aldosterone Inhibitors
J Am Coll Cardiol 2023 Jan 31;81(4)321-331, E Eworuke, EC Welch, N Haug, C Horgan, HS Lee, Y Zhao, TY HuangFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.